5 Best Healthcare Stocks For the Long-Term

4. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)

Number of Hedge Fund Investors In Q3 2023: 24

Latest P/E Ratio: 13.11

5-Yr Average Annualized Revenue Growth: 318%

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is an American company making treatments for nervous system disorders. The firm had a strong third quarter that saw it maintain its growth trajectory by posting 37% annual revenue growth.

By the end of this year’s third quarter, 24 out of the 910 hedge funds polled by Insider Monkey were the firm’s shareholders. Albert Cha and Frank Kung’s Vivo Capital was Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)’s biggest shareholder as it owned 2.6 million shares that are worth $85.4 million.

Follow Harmony Biosciences Holdings Inc. (NASDAQ:HRMY)